Financial burden in recipients of allogeneic hematopoietic cell transplantation
- PMID: 24867778
- DOI: 10.1016/j.bbmt.2014.05.011
Financial burden in recipients of allogeneic hematopoietic cell transplantation
Abstract
Although allogeneic hematopoietic cell transplantation (HCT) is an expensive treatment for hematological disorders, little is known about the financial consequences for the patients who undergo this procedure. We analyzed factors associated with its financial burden and its impact on health behaviors of allogeneic HCT recipients. A questionnaire was retrospectively mailed to 482 patients who underwent allogeneic HCT from January 2006 to June 2012 at the Mayo Clinic, to collect information regarding current financial concerns, household income, employment, insurance, out-of-pocket expenses, and health and functional status. A multivariable logistic regression analysis identified factors associated with financial burden and treatment nonadherence. Of the 268 respondents (56% response rate), 73% reported that their sickness had hurt them financially. All patients for whom the insurance information was available (missing, n = 13) were insured. Forty-seven percent of respondents experienced financial burden, such as household income decreased by >50%, selling/mortgaging home, or withdrawing money from retirement accounts. Three percent declared bankruptcy. Younger age and poor current mental and physical functioning increased the likelihood of financial burden. Thirty-five percent of patients reported deleterious health behaviors because of financial constraints. These patients were likely to be younger, have lower education, and with a longer time since HCT. Being employed decreased the likelihood of experiencing financial burden and treatment nonadherence due to concern about costs. A significant proportion of allogeneic HCT survivors experience financial hardship despite insurance coverage. Future research should investigate potential interventions to help at-risk patients and prevent adverse financial outcomes after this life-saving procedure.
Keywords: Allogeneic hematopoietic cell transplantation; Economics; Financial burden; Quality of life.
Copyright © 2014 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Financial Hardship and Patient-Reported Outcomes after Hematopoietic Cell Transplantation.Biol Blood Marrow Transplant. 2016 Aug;22(8):1504-1510. doi: 10.1016/j.bbmt.2016.05.008. Epub 2016 May 13. Biol Blood Marrow Transplant. 2016. PMID: 27184627 Free PMC article.
-
Financial impact of allogeneic hematopoietic cell transplantation on patients and families over 2 years: results from a multicenter pilot study.Bone Marrow Transplant. 2016 Sep;51(9):1233-40. doi: 10.1038/bmt.2016.103. Epub 2016 Apr 18. Bone Marrow Transplant. 2016. PMID: 27088381 Free PMC article.
-
Association of socioeconomic status with long-term outcomes in 1-year survivors of allogeneic hematopoietic cell transplantation.Bone Marrow Transplant. 2015 Oct;50(10):1326-30. doi: 10.1038/bmt.2015.166. Epub 2015 Jul 20. Bone Marrow Transplant. 2015. PMID: 26191953
-
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.Dan Med Bull. 2007 May;54(2):112-39. Dan Med Bull. 2007. PMID: 17521527 Review.
-
Goals for Pay for Performance in Hematopoietic Cell Transplantation: A Primer.Biol Blood Marrow Transplant. 2015 Aug;21(8):1367-72. doi: 10.1016/j.bbmt.2015.04.014. Epub 2015 Apr 16. Biol Blood Marrow Transplant. 2015. PMID: 25889042 Review.
Cited by
-
A mixed methods analysis of perceived cognitive impairment in hematopoietic stem cell transplant survivors.Palliat Support Care. 2019 Aug;17(4):396-402. doi: 10.1017/S1478951518000664. Palliat Support Care. 2019. PMID: 30238868 Free PMC article.
-
Relationship between paid leave, financial burden, and patient-reported outcomes among employed patients who have undergone bone marrow transplantation.Qual Life Res. 2019 Jul;28(7):1835-1847. doi: 10.1007/s11136-019-02150-8. Epub 2019 Apr 27. Qual Life Res. 2019. PMID: 31030364 Free PMC article.
-
Association of Macroeconomic Factors With Nonrelapse Mortality After Allogeneic Hematopoietic Cell Transplantation for Adults With Acute Lymphoblastic Leukemia: An Analysis From the Acute Leukemia Working Party of the EBMT.Oncologist. 2016 Mar;21(3):377-83. doi: 10.1634/theoncologist.2015-0314. Epub 2016 Feb 11. Oncologist. 2016. PMID: 26869584 Free PMC article.
-
A theoretical model of financial burden after cancer diagnosis.Future Oncol. 2020 Dec;16(36):3095-3105. doi: 10.2217/fon-2020-0547. Epub 2020 Sep 25. Future Oncol. 2020. PMID: 32976048 Free PMC article.
-
Age and gender differences in financial distress among hematopoietic cell transplant survivors.Support Care Cancer. 2020 Sep;28(9):4361-4371. doi: 10.1007/s00520-019-05291-1. Epub 2020 Jan 8. Support Care Cancer. 2020. PMID: 31916007 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources